NM_004990.4:c.2391A>C

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The NM_004990.4(MARS1):​c.2391A>C​(p.Thr797Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000806 in 1,611,908 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00082 ( 1 hom. )

Consequence

MARS1
NM_004990.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00009324
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.561

Publications

2 publications found
Variant links:
Genes affected
MARS1 (HGNC:6898): (methionyl-tRNA synthetase 1) This gene encodes a member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. The encoded protein is a component of the multi-tRNA synthetase complex and catalyzes the ligation of methionine to tRNA molecules. [provided by RefSeq, Jan 2011]
MARS1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease axonal type 2U
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • severe early-onset pulmonary alveolar proteinosis due to MARS deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • autosomal recessive spastic paraplegia type 70
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • spastic paraplegia 70, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • trichothiodystrophy 9, nonphotosensitive
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.031).
BP6
Variant 12-57515336-A-C is Benign according to our data. Variant chr12-57515336-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 389593.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000702 (107/152344) while in subpopulation AMR AF = 0.00124 (19/15302). AF 95% confidence interval is 0.000813. There are 0 homozygotes in GnomAd4. There are 52 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MARS1NM_004990.4 linkc.2391A>C p.Thr797Thr splice_region_variant, synonymous_variant Exon 18 of 21 ENST00000262027.10 NP_004981.2 P56192-1
MARS1XM_047428851.1 linkc.1689A>C p.Thr563Thr splice_region_variant, synonymous_variant Exon 14 of 17 XP_047284807.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MARS1ENST00000262027.10 linkc.2391A>C p.Thr797Thr splice_region_variant, synonymous_variant Exon 18 of 21 1 NM_004990.4 ENSP00000262027.5 P56192-1

Frequencies

GnomAD3 genomes
AF:
0.000690
AC:
105
AN:
152226
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000776
AC:
193
AN:
248650
AF XY:
0.000810
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000957
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00110
Gnomad OTH exome
AF:
0.000820
GnomAD4 exome
AF:
0.000817
AC:
1193
AN:
1459564
Hom.:
1
Cov.:
32
AF XY:
0.000870
AC XY:
632
AN XY:
726102
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33478
American (AMR)
AF:
0.000918
AC:
41
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.00214
AC:
56
AN:
26114
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.000487
AC:
42
AN:
86224
European-Finnish (FIN)
AF:
0.0000194
AC:
1
AN:
51480
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.000866
AC:
963
AN:
1111750
Other (OTH)
AF:
0.00106
AC:
64
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000702
AC:
107
AN:
152344
Hom.:
0
Cov.:
32
AF XY:
0.000698
AC XY:
52
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41586
American (AMR)
AF:
0.00124
AC:
19
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000956
AC:
65
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.00100
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00218
EpiControl
AF:
0.00178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 17, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 14, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Charcot-Marie-Tooth disease axonal type 2U;C4225400:Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency Uncertain:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects codon 797 of the MARS mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MARS protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs140573721, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 389593). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MARS1-related disorder Benign:1
Dec 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
6.1
DANN
Benign
0.74
PhyloP100
-0.56
PromoterAI
-0.021
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000093
dbscSNV1_RF
Benign
0.040
SpliceAI score (max)
0.26
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.26
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140573721; hg19: chr12-57909119; API